Panagiotis
Manesiotis
*,
Qendresa
Osmani
and
Peter
McLoughlin
Pharmaceutical and Molecular Biotechnology Research Centre, Waterford Institute of Technology, Waterford, Ireland. E-mail: pmanesiotis@wit.ie; Fax: +353 (0)51 302679; Tel: +353 (0)51 306167
First published on 1st May 2012
Molecularly Imprinted Polymers (MIPs) against S-ibuprofen were synthesised using a tailor made functional monomer, 2-acrylamido-4-methylpyridine, following extensive pre-polymerisation studies of template–monomer complexation. An apparent association constant of 340 ± 22 M−1 was calculated that was subsequently corrected to account for dimerisation of ibuprofen (Kdim = 320 ± 95 M−1) resulting in an intrinsic association constant of 715 ± 16 M−1, consistent with previously reported values. Using the synthesised imprinted polymer as a stationary phase, complete resolution of a racemic mixture of ibuprofen was achieved in predominantly aqueous mobile phases. An imprinting factor of 10 was observed, and was found to be in agreement with the difference in the average number of binding sites between MIP and blank polymers, calculated by staircase frontal chromatography. The imprinted polymers exhibited enhanced selectivity for the templated drug over structurally related NSAIDs. When applied as sorbents in solid-phase extraction of ibuprofen from commercial tablets, urine and blood serum samples, recoveries up to 92.2% were achieved.
These shortfalls have been overcome by designing functional monomers capable of forming strong interactions with a particular template, thus eliminating the need for an excess of functional monomer and therefore reducing the degree of non-specific binding.8–11 Stoichiometric ratios of the functional monomer and the template are used at the pre-polymerisation stage, forming strong pre-polymerisation complexes, which subsequently generate imprinted polymers with high affinity binding sites.
Ibuprofen is a member of the non-steroidal anti-inflammatory drugs (NSAIDs) and is commonly used for relief from arthritis, fever and as a generic pain reliever. Being one of the most popular drugs of its category, it has attracted significant research interest over the past years, and a number of reports of its targeting by molecular imprinting are found in literature. An early study by Kempe and Mosbach investigated the enantio-selective properties of S-naproxen imprinted polymers prepared using 4-VPy as the functional monomer.12 Enantio-separation of a racemic mixture of naproxen was achieved using an organic mobile phase, with a separation factor of 1.65. Caro et al. prepared ibuprofen imprinted polymers using a similar monomer composition and used it as an SPE sorbent for selective extraction of ibuprofen, naproxen, benzoic acid, fenoprofen and diclofenac from spiked river water samples.13 The polymer was capable of selective extraction of the tested analytes and performed similarly to a commercial SPE sorbent. However, chromatographic evaluation of the imprinted polymer revealed rather low imprinting factors for ibuprofen and naproxen. In another study, Haginaka et al. prepared S-ibuprofen imprinted beads, generated by multi-step swelling and a thermal polymerisation method.14 The imprinted beads were employed as a HPLC chromatographic stationary phase using a mixture of organic–aqueous mobile phases. An imprinting factor of 2.08 was calculated for S-ibuprofen, while it was lower for structurally related compounds. Furthermore, only partial enantio-separation of ibuprofen enantiomers was achieved. In a more recent study Spegel et al. prepared imprinted polymers by in situ polymerisation for enantiomeric separation of ibuprofen using capillary electrochromatography.15 Although a range of polymers with varying compositions of the starting materials were prepared using 4-VPy as the functional monomer, only partial separation of enantiomers was achieved.
In contrast to previous reports detailed above, where commercially available 4-VPy was used as the functional monomer, the work presented here details the design and preparation of S-ibuprofen-specific stoichiometric imprinted polymers using a tailor-made functional monomer, 2-acrylamido-4-methylpyridine.16 Initially, an in-depth investigation of pre-polymerisation complexes was performed using NMR spectroscopy, whereby it was possible to deconvolute the apparent association constant from the dimerisation of ibuprofen itself, reported here for the first time. The subsequently synthesised imprinted polymer was employed as a chromatographic stationary phase. Using a 30 mm HPLC column and a predominantly aqueous mobile phase, the imprinted polymer was capable of complete enantiomeric separation of racemic ibuprofen in less than 30 minutes. Furthermore, selectivity of the imprinted polymer was demonstrated by the superior specific binding of S-ibuprofen compared to its structurally related compounds (Scheme 1) with calculated imprinting factors of up to 10. The imprinted polymer was also used as a selective SPE sorbent for the extraction of ibuprofen from commercial tablets, blood serum and urine samples with recoveries of up to 92.2%.
![]() | ||
Scheme 1 Proposed mode of interaction between the functional monomer (AMP) and S-ibuprofen plus the chemical structures of related NSAIDs. |
NMR spectra were obtained using a Jeol ECX 400 spectrometer (Tokyo, Japan). HPLC measurements were performed using an Agilent 1200 system equipped with a diode array detector. Surface area analysis was performed using a Micromeritics Gemini VI Nitrogen sorption analyser (Particular Sciences, Dublin, Ireland).
Staircase frontal chromatography was performed using solutions of S-ibuprofen in acetonitrile as the mobile phase, ranging from 0.001 to 0.1 mol L−1, and mixing them in a step-wise fashion of 10% increments with pure acetonitrile to produce a staircase frontal chromatogram with a total of 30 steps. From each step the corresponding amount of bound analyte was calculated and the collected results were plotted against the corresponding concentration of S-ibuprofen to produce binding isotherms that were fitted using the Freundlich binding model.20,21
![]() | ||
Fig. 1 1H NMR titration binding isotherm of S-ibuprofen with AMP: experimental data (triangles), corresponding fitted curve (dashed line), data corrected for self-association of ibuprofen (squares) and corresponding fitted curve (solid line). Insert: S-ibuprofen self-association isotherm obtained by 1H NMR dilution study and corresponding fitted curve. |
The stoichiometry of the AMP–ibuprofen complex was verified by a Job plot experiment. This showed a maximum at XAMP = 0.5, verifying the 1:
1 stoichiometry as expected by the two point interaction postulated in Scheme 1 and supporting our use of a stoichiometric imprinting protocol.
Following Soxhlet extraction of the polymers, 13C solid state NMR analysis of the materials was performed with nearly identical spectra obtained, as seen in Fig. 2. Spin-lattice (T1) relaxation times were also measured by inversion recovery experiments and were found to be 0.6 seconds for the MIP and 0.55 seconds for the NIP, demonstrating the comparable physical character of the two polymers.
![]() | ||
Fig. 2 13C solid state NMR spectra (100 MHz) of imprinted (top) and non-imprinted polymers (bottom) with assignment of major peaks. |
The retention profiles of the other injected analytes also revealed some interesting trends. The much smaller analyte 2-phenylpropanoic acid, as well as larger indoprofen, were less retained, similarly to the geometrically different naproxen and ketoprofen (Table 1). It is however noteworthy that of all analytes tested, S-flurbiprofen and S-naproxen, both comparable in size and shape to the templated S-ibuprofen, exhibited slightly higher retention than the other analytes tested, highlighting a size-exclusion effect taking place within the polymer's binding sites. Furthermore, the slightly more acidic character of these analytes, as calculated using Marvin software package,23 might also be responsible for their marginally longer retention. It should be noted here that in all cases no enantio-separation was observed when racemic mixtures were injected.
Analyte | CH3CN | CH3CN–H2O (40![]() ![]() |
||
---|---|---|---|---|
Imprinted | Non-imprinted | Imprinted | Non-imprinted | |
S-Ibuprofen | 6.5 | 2.2 | 17.0 | 2.5 |
R-Ibuprofen | 4.5 | 2.2 | 10.2 | 2.5 |
S-Flurbiprofen | 7.3 | 4.6 | 16.3 | 2.4 |
R-Flurbiprofen | 7.3 | 4.6 | 12.0 | 2.4 |
S-Naproxen | 7.5 | 3.6 | 9.2 | 2.0 |
S-Ketoprofen | 3.9 | 5.6 | 5.8 | 1.7 |
R-Ketoprofen | 3.9 | 5.6 | 5.8 | 1.7 |
S-2-PPA | 4.5 | 3.6 | 3.5 | 1.4 |
R-2-PPA | 4.5 | 3.6 | 3.5 | 1.4 |
S-Indoprofen | 7.5 | 6.0 | 4.3 | 1.5 |
R-Indoprofen | 7.5 | 6.0 | 4.3 | 1.5 |
In order to optimise the mobile phase composition, the percentage of water in acetonitrile was incremented in steps of 10%. When 60% water content was used, complete resolution of ibuprofen enantiomers was achieved in approximately 30 minutes and an α = 1.8 was calculated, while the imprinting factor for S-ibuprofen was equal to 10, a 5-fold increase compared to previously reported literature values. The composition of each of the two peaks was verified by injection of pure S-ibuprofen and it was verified that this was the longer retained enantiomer, while the non-templated R-enantiomer eluted first. At water contents higher than 70% chromatographic run times exceeded 60 minutes and the quality of the peaks diminished significantly, hence 60% water content was used for the further evaluation of the polymers. The obtained imprinting factors are presented in Fig. 3.
![]() | ||
Fig. 3 Imprinting factors (kMIP/kNIP) for ibuprofen and structurally related compounds in CH3CN and CH3CN–H2O (40![]() ![]() ![]() ![]() |
As expected, the relative hydrophobic character of NSAIDs resulted in significantly longer retention of all injected analytes, compared to the analyses in pure organic medium, with S-flurbiprofen and S-naproxen being retained the longest compared to the other structurally related analytes. Moreover the imprinted polymer exhibited enantio-selectivity for flurbiprofen as its racemic mixture was nearly completely resolved (α = 1.4). This result was attributed to the comparable size and shape of this analyte to the templated structure.
Further optimisation of the chromatographic conditions was attempted by means of temperature control. Thus, a series of injections of rac-ibuprofen was performed at 20, 40 and 60 °C and the elution profiles were recorded. It was observed that although peak symmetry improved and run times were reduced from 30 to 10 minutes as the temperature increased, the resolution was dramatically affected and separation factors decreased from 1.8 at 20 °C to 1.5 at 40 °C and 1.35 at 60 °C. It was thus decided that further experiments should be run at 20 °C (Fig. 4).
![]() | ||
Fig. 4 Elution profiles of 0.1 mmol L−1rac-ibuprofen injected on the S-ibuprofen imprinted column. From bottom to top: column temperature 20 °C, 40 °C and 60 °C. Dashed line: 0.1 mmol L−1S-ibuprofen injected on S-ibuprofen imprinted column at 20 °C. Traces are shown in scale but have been off-set on the y-axis for clarity. Insert: 1 mmol L−1rac-ibuprofen injection at 20 °C. Mobile phase: CH3CN–H2O (40![]() ![]() |
Once the optimum chromatographic conditions were established, direct analysis of a commercial ibuprofen tablet was attempted. The tablet was ground to a fine powder and 20 mg were dissolved in 10 mL of CH3CN–H2O 40:
60. This solution was injected directly on the MIP LC column and while all excipients eluted near the solvent front, we were able to resolve the two enantiomers of ibuprofen found in the formulation and achieve accurate determination of the drug concentration.
Finally, a staircase frontal chromatography experiment was performed, using the optimised chromatographic conditions described above. A wide range of S-ibuprofen concentrations was tested from 10−6 mol L−1 to 10−3 mol L−1 and a total of 30 points were collected for each column (MIP and NIP). The amounts of bound analyte during each step were then plotted against the corresponding analyte concentration and two binding isotherms were constructed (Fig. 5). The imprinted polymer clearly exhibits significantly higher affinity for S-ibuprofen throughout the range of concentrations tested, compared to the non-imprinted polymer. The plotted curves were fitted to the Freundlich isotherm q = aCm, where q is the amount of adsorbed analyte, a is a coefficient, C the concentration of the analyte in the mobile phase and m the heterogeneity index. Parameters a and m where calculated by non-linear regression of the experimental data and using the equations detailed in the article by Umpleby et al.,21 the average affinity constant K and the average number of binding sites N were extracted. Interestingly, the Freundlich model calculated that both MIP and NIP polymers have the same average affinity constant of 1.47 ± 0.02 × 104 M−1. However, the difference in the performance of the two polymers regarding the retention of S-ibuprofen as established by chromatographic evaluation, can be attributed to the starkly different average number of binding sites, with the MIP containing 2.19 ± 0.01 μmol g−1 and the NIP 0.23 ± 0.01 μmol g−1. The similarity of affinity constants could be ascribed to the fact that both polymers contain the same ingredients, and more importantly the same functional monomer, while the introduction of S-ibuprofen at the pre-polymerisation mixture is responsible for the generation of specific recognition points, hence the nearly 10-fold difference in average number of binding sites, clearly demonstrated by the corresponding affinity distribution plot (Fig. 5, insert). This difference is in remarkable agreement with the calculated imprinting factor for S-ibuprofen discussed previously.
![]() | ||
Fig. 5 Binding isotherms of S-ibuprofen on MIP (◆) and NIP (◇) columns and corresponding curves fitted to the Freundlich isotherm model (dashed lines). Insert: affinity distribution plots. |
![]() | ||
Fig. 6 Ibuprofen recovery (%) dependence on CH3CN content in the wash step (bars) and corresponding imprinting factors (dashed line). |
Based on these results and the common assumption that imprinted polymers perform best when applied in the solvent which was used as a porogen during their synthesis, we decided to use toluene as the organic solvent at the molecular recognition step. Hence, after loading the sample, the polymer phase was washed with 2 mL of toluene, followed by complete drying of the bed and finally elution of the retained analyte. Indeed, this protocol resulted in recoveries averaging 86.3% on the MIP column and 29.1% on the NIP, a ratio of 3, verifying the above hypothesis.
We then modified this protocol adding an aqueous wash after loading the sample to remove any water soluble compounds from the column, and applied it in the extraction of commercial ibuprofen tablets, as well as spiked (200 μg mL−1) blood serum and urine samples. The results are summarised in Table 2. Recoveries from ibuprofen tablets were comparable to the ones obtained from aqueous standards although the differences between MIP and NIP were smaller. Furthermore, significantly reduced recoveries were initially achieved from urine and blood serum samples averaging just 24.1% at physiological pH. This was ascribed to the acidic character of ibuprofen that is found in the carboxylate anion form at pH values near 7. In this form, the donor–acceptor array is no longer present, hence the analyte is not complementary to the functional monomer. Consequently, when the pH was reduced to 4 by addition of a few drops of 1 M aqueous HCl, recoveries of up to 92.2% were achieved, confirming the proposed two-point hydrogen bond complexation.
Sample | Imprinted | Non-imprinted |
---|---|---|
H2O | 86.3 ± 2 | 29.1 ± 2 |
Tablet | 84.7 ± 3 | 50.0 ± 4 |
Blood serum | 92.2 ± 4 | 56.8 ± 2 |
Urine | 87.3 ± 3 | 47.1 ± 4 |
It should be noted here that throughout this series of SPE experiments, totalling at least 100 extraction cycles, the same 25 mg MIP cartridge was used and no loss in performance or reproducibility was evident, verifying the robustness and reusability of imprinted materials compared to biological affinity media.
The results presented here, when directly compared to previous reports found in literature, clearly demonstrate that imprinted materials with superior performance are readily accessible using simple, custom-made building blocks, optimised for each targeted analyte.
This journal is © The Royal Society of Chemistry 2012 |